Connect with us

Market Reports

‘title here3’

Published

on

Press Release

‘content here’

Bob Melanian

Latest posts by Bob Melanian (see all)

Continue Reading

Global Market

Global Enzymatic Wound Debridement Market Is Expected to Grow at A CAGR of 6.1% From 2020 To 2027

Published

on

Press Release

Enzymatic wound debridement products comprise of papain, collagenase, fibrinolysis, and deoxyribonucleases. Papain is derived from the papaya fruit, collagenase form bacteria, and deoxyribonucleases and fibrinolysins from the bovine extracts. Technological advancement in the development of the enzymatic wound debridement products will further propel the market growth during the forecast period.

Acute wounds are reigning the type segment for enzymatic wound debridement market. The acute wounds comprise of the following types of wounds such as lacerations, burns, incisions, and punctures, etc. which is experienced by human beings at least once during their lifetime. Chronic wounds are expected to record rapid market growth during the forecast period owing to the rising prevalence of diabetic foot ulcers worldwide. A constant rise in the number of surgeries performed throughput the globe further propel its market growth.

Browse the full report Enzymatic Wound Debridement Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/enzymatic-wound-debridement-market

Collagenase is currently dominating the product segment for enzymatic wound debridement market. Collagenase products are highly popular among surgeons owing to its ability to promote the granulation process to enhance the epithelialization of skin cells. It is critical in shifting the wound healing process from the inflammatory stage to the proliferative stage. A constant rise in diabetic foot ulcers and venous leg ulcers worldwide drives its market growth. Papain is considered the most suitable option for tending large wounds manifesting sepsis and cellulite. It is either used in combination with urea or saline solution depending on the degree of tissue necrosis at the wound site.

North America is currently leading the geography segment for enzymatic wound debridement market. The key factor responsible for its market growth is the rising prevalence of diabetic foot ulcers in the region. According to the recent statistics provided by the Center for Disease Control and Prevention (CDC), approximately 34.2 million people in the United States are suffering from diabetes. Furthermore, the presence of major players such as Mölnlycke Health Care AB, Coloplast Corp., ConvaTec Group, Plc., Medline Industries, Inc., etc. further accentuates the market growth in the region. Europe is in the 2nd position in the regional segment on account of the affordable reimbursement scenario for the enzymatic wound debridement products employed for the treatment of pressure ulcers in the region. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. Significant increase in the acute wounds associated with domestic accidents and constant rise in the chronic wounds associated with diabetic foot ulcers and pressure ulcers together drive the market growth in the Asia Pacific region.

Pharmaceutical manufacturers actively engaged in the production of enzymatic wound debridements are Mölnlycke Health Care AB., Smith & Nephew, Plc., ConvaTec Group, Plc., Coloplast Corp., Medline Industries, Inc., B. Braun Melsungen AG., Integra LifeSciences, PAUL HARTMANN Limited, Arobella Medical, LLC and Advancis Medical.

Market Key Takeaway:

  • Rising prevalence of diabetic foot ulcer worldwide
  • A constant rise in the number of surgeries performed worldwide
  • Supportive regulatory environment provided by the global healthcare agencies for the enzymatic wound debridement market

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Bob Melanian

Latest posts by Bob Melanian (see all)

Continue Reading

Global Market

Global Oxycodone Hydrochloride Market is expected to grow at a CAGR of 1.8% from 2020 to 2027

Published

on

Press Release

Oxycodone hydrochloride binds on the mu-receptors present in the central nervous systems and mimics the endogenous opiates. It is under strict government regulation and supervision to prevent its abuse of opioid addiction in patients using it for the long term in managing chronic pain.

Acute pain management is spearheading the clinical application segment for the oxycodone market. The nature of acute pain is sudden and episodic, it last form a few weeks to almost six months. Medical ailments such as surgery, broken bones, dental works, mild lacerations, and burns, etc. are associated with acute pain. Physicians usually prescribe a low dose of an opioid analgesic is given to patients for treating the pain and the patient can resume a normal lifestyle. Chronic pain is gaining tremendous traction owing to the rising prevalence of cancer and musculoskeletal disorders worldwide. Chronic pain is continuous and throbbing in nature, medical conditions such as arthritis, fibromyalgia, cancer, etc. are associated with chronic pain. It is prescribed in combination with other painkillers with dose adjusted to negate any possible opioid addiction due to its long term use.

Browse the full report Oxycodone Hydrochloride Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/oxycodone-hydrochloride-market

Hospital pharmacy is currently dominating the distribution channel segment for the oxycodone hydrochloride market.  Stringent regulation and supervision are maintained regarding the compounding of Opioid analgesics as a medicine for pain management. Hospital pharmacist ensures accurate drug posology in accordance with a doctor’s prescription to negate opioid addiction. Retail pharmacy is going to register comfortable market growth on account of the availability of different combinations of opioid analgesics with other NSAIDS in generic versions. The ability to cater to drugs at discounted prices to poor patients accentuates its market growth.

North America is leading the geography segment for the oxycodone hydrochloride market. As per the research citings presented by the American Cancer Society (ACS) approximately 606,520 cancer deaths will occur in the United States by 2020. Domicile of key players such as Pfizer, Inc., Apotex Corporation, Purdue Pharma, etc. further propels its market growth in the region. The market growth in the European region is primarily driven by the rising prevalence of musculoskeletal disorders. As per the latest information furnished by the World Health Organization (WHO), approximately 24.7% of workers in the European Union complain of backache and 22.8% with muscular pain respectively. A combination dose of opioid analgesic and other painkillers are employed to manage pain associated with musculoskeletal disorders in the region. Asia Pacific is set to register comfortable market growth in the region on account of the rising prevalence of occupational hazards and cancer patients and effective implementation of guidelines pertaining to the judicious use of opioid analgesic as a pain management therapy.

Pharmaceutical companies actively engaged in the manufacturing of oxycodone hydrochloride are Pfizer, Inc., Teva Pharmaceutical Industries Ltd, Apotex Corporation, Mallinckrodt Pharmaceuticals, Purdue Pharma, Daiichi Sankyo Company Limited., Acura Pharmaceuticals., Lupin Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., and Siegfried AG.

Market Key Takeaways:

  • Rising prevalence of cancer and musculoskeletal disorder patients suffering from acute and chronic pain
  • Technological advancement in the formulation and development of opioid alkaloids with other painkillers to negate any possible opioid addiction due to its long term use
  • Affordable reimbursement scenario for oxycodone hydrochloride formulation used in pain management therapy

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Bob Melanian

Latest posts by Bob Melanian (see all)

Continue Reading

Global Market

Global Medical Aesthetics Market is expected to grow at a CAGR of 7.7% from 2020 to 2027

Published

on

Press Release

Medical aesthetics is a discipline of cosmetic surgery that deals in restoring the external appearance and increasing self-confidence in people suffering from facial defects and skin injuries. Increasing celebrity cult and constant rise in per capita income of middle-income households worldwide increase the demand for the medical aesthetics market. The major limitation associated with this market is the frequent product recall and lack of reimbursement scenario for the medical aesthetic products and procedures.

In the present situation, facial aesthetics represents the largest market share in the product segment of the medical aesthetics market. The primary contributing factors that eventually restore its market dominance are a significant rise in the elderly population worldwide and a growing inclination towards minimally invasive surgical procedures to perform, rhinoplasty, forehead lift, an eyebrow lift. Furthermore, the availability of a diverse range of cosmetic products which helps in restoring facial beauty further increases the facial aesthetics market growth. Body contouring is considered to be the rampantly growing segment on account of the increasing demand for performing liposuction, breast augmentation, gluteal implants, etc. A significant rise in obesity and technological advancement in the devices employed to restore body contouring will further fortify its market demand.

Browse the full report Medical Aesthetics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027 at https://www.atlanticmarketresearch.com/medical-aesthetics-market

Non-invasive procedures are currently dominating the medical aesthetics market. Increasing awareness regarding its applicability in restoring facial defects and cost-effective nature determines its superiority in the medical aesthetics market. Nd: YAG laser, chemical peels, and dermabrasion are quite effective in removing facial hair, acne scars, and molds with less side effects post-procedure.  Invasive procedures are popular among consumers in order to restore body contouring and to perform breast augmentation, gluteal implants, etc. A significant rise in dental deformities and maxillofacial complications will further provide a positive impetus to the surgical procedures demand in the medical aesthetics market.

North America is spearheading the geography segment for the medical aesthetics market. According to the latest statistics provided by the American Society of Plastic Surgeons (ASPS) in 2017, more than 17.5 million medical aesthetic surgical procedures pertaining to cosmetics were performed in the United States. Constant rise in geriatric population and growing inclination in restoring the external body contouring together determine the medical aesthetics market growth in the region. Furthermore domicile of key players such as Merz Pharma, Allergan Plc., SculpSure, Johnson& Johnson, etc. will further accentuate the market growth in the region. Europe stands in the 2nd position in the geography segment for the medical aesthetics market. The supportive regulatory environment provided by the European Regulatory Agency (EMA) for the early clearance of medical aesthetic devices will determine the market growth in the European Union region. Asia Pacific is anticipated to register remarkable growth in the near future. Significant rise in the number of cases pertaining to skin burns, dental deformities, and facial trauma will propel the market growth in the region. Moreover constant rise in per capita income of middle-income households and a significant rise in the medical tourism industry will further bolster the market growth in the Asia Pacific region.

Medical device companies actively engaged in the manufacturing and marketing of medical aesthetics are Allergan, Plc., Johnson & Johnson, Dentsply Sirona, SculpSure, Establishment Labs, Galderma S.A., VENUSCONCEPT, Implantech, and Merz Pharma GmbH.

Market Key Takeaways:

  • Significant rise in the number of elderly population worldwide and increasing demand for medical aesthetic products and procedures
  • Supportive regulatory environment provided by the regulatory agencies worldwide for the early clearance of medical aesthetic products

About Atlantic Market Research

Atlantic Market Research is the largest provider of market research and consulting services.

Research and consulting services of Atlantic Market Research help businesses across the globe navigate the challenges in a rapidly growing marketplace with confidence. Our customized and syndicated market research reports deliver sufficient insights that drive sustainable growth.

Contact:
Mr. Trevor Wilson
Atlantic Market Research
911 Central Ave #268
Albany, NY 12206, USA

Website: https://www.atlanticmarketresearch.com
Email: [email protected]

Bob Melanian

Latest posts by Bob Melanian (see all)

Continue Reading

Trending

Copyright © 2019 Melanian News